Floatz logo

Givinostat

Duchenne and Becker Muscular Dystrophy

ItalfarmacoSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Duchenne and Becker Muscular Dystrophy cohort.

Asset / SponsorPhaseRating
Zeleciment Rostudirsen
Dyne Therapeutics
Phase 3B
Ataluren
PTC Therapeutics
Phase 3B
ARG
Massachusetts General Hospital
Phase 1CC
MOXIFLOXACIN
Italfarmaco
Phase 1CC

Same molecule, other indications

Givinostat is also rated in:

Duchenne muscular dystrophyDormant
BB
Indicative ·
64 / 100
View asset →
Becker muscular dystrophyDormant
CCC
Indicative ·
54 / 100
View asset →
Hodgkins lymphomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →